India's DMPLOI - Jobs & Networking App
Intas Pharma- Walk in Interview on Thursday, 6th July 2023 | Parenteral (Injectable) Packing, Tablet (Solid Oral) Packing department
Join a leading global pharmaceutical organisation
Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happiness and hope.
WALK-IN INTERVIEW
1)Position: JR. OFFICER TO SR. OFFICER
Department: Parenteral (Injectable) Packing
Qualification: B.Pharma / M.Pharma / B.Sc / M.Sc Experience: 2 to 5 years
Experience in Parenteral Packing, Visual Inspection, Track and Trace, labelling, BPCR, Packing Planning & Documentation.
2)Position: JR. OFFICER TO SR. OFFICER
Department: Tablet (Solid Oral) Packing
Qualification: B.Pharma / M.Pharma / B.Sc / M.Sc Experience: 2 to 5 years
Experience in Primary/Secondary Tablet Packing Area. Should have good knowledge Track and Trace system, CAPA, Deviation, Change Control, Prepare SOP and another cGMP documents skills.
Intas Pharmaceuticals Walk In Interview at Pharmez
Date: Thursday, 6th July 2023
Time: 09:00 AM to 01:00 PM
Venue: Intas Pharmaceuticals Limited Plot No.05 to 14, Pharmez, Near Village Matoda, Sarkhej – Bavla Highway 8-A, Ta Sanand, Dist- Ahmedabad.
JOB LOCATION: INTAS PHARMEZ, AHMEDABAD
Please Note: Intas Pharmaceuticals Ltd. does not directly or indirectly charge any fee for job application, processing, training or testing. Do not participate in any such invitations.
•Please carry your updated resume all educational, experience & salary documents
• Candidates who have appeared for an interview at Intas in the last six months are requested not to apply
• Candidates must be open to work in shift duties and having pharma experience in regulated plant like USFDA, MHRA should apply.
